These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 228024)

  • 1. Unimpaired beta adrenergic responses during prazosin administration.
    Buzzeo LA; Steele JM; Lowenstein J
    J Pharmacol Exp Ther; 1979 Nov; 211(2):345-9. PubMed ID: 228024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic tools for assessment of adrenergic nerve activity in human hypertension.
    Ibsen H; Julius S
    Fed Proc; 1984 Jan; 43(1):67-71. PubMed ID: 6317465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of decreased plasma substance P levels in human essential hypertension and influence of prazosin treatment.
    Faulhaber HD; Rathsack R; Rostock G; Homuth V; Pfeiffer D; Naumann E; Hartrodt W; Görne RC; Oehme P
    Biomed Biochim Acta; 1983; 42(7-8):1019-25. PubMed ID: 6197065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral beta-receptor responsiveness in patients with essential hypertension.
    McAllister RG; Love DW; Guthrie GP; Dominic JA; Kotchen TA
    Arch Intern Med; 1979 Aug; 139(8):879-81. PubMed ID: 223509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prazosin and renal hemodynamics: arteriolar vasodilation during therapy of essential hypertension in man.
    Preston RA; O'Connor DT; Stone RA
    J Cardiovasc Pharmacol; 1979; 1(3):277-86. PubMed ID: 94396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine potentiates vasodilator-induced renin release.
    Tofovic SP; Branch KR; Oliver RD; Magee WD; Jackson EK
    J Pharmacol Exp Ther; 1991 Mar; 256(3):850-60. PubMed ID: 2005584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-and alpha-adrenergic blockade and metabolic responses to insulin induced hypoglycaemia in diabetics.
    Odugbesan O; Toop M; Barnett AH
    Diabetes Res; 1987 Jul; 5(3):135-8. PubMed ID: 2822334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An effect of extrarenal beta adrenergic stimulation on the release of renin.
    Reid IA; Schrier RW; Earley LE
    J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension in rats.
    Keen HL; Brands MW; Alonso-Galicia M; Hall JE
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1192-9. PubMed ID: 8972890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between the renin-angiotensin and beta adrenergic nervous systems in drinking and pressor responses after renal artery constriction.
    Atkinson J; Lüthi P; Péra-Bally R; Peters-Haefeli L
    J Pharmacol Exp Ther; 1982 May; 221(2):453-60. PubMed ID: 6281416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic arterial hypertension: pathogentic role of the sympathetic nervous system].
    Andrejak M; Simon A; Hardin JM; Fournier A; Safar M; Quichaud J
    Nouv Presse Med; 1977 Dec; 6(42):3963-7. PubMed ID: 600739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors.
    De Feo P; Bolli G; Perriello G; De Cosmo S; Compagnucci P; Angeletti G; Santeusanio F; Gerich JE; Motolese M; Brunetti P
    Diabetes; 1983 Oct; 32(10):887-93. PubMed ID: 6311652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
    Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
    Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Central cardiovascular effect of isoprenaline and some adrenergic beta blocking agents in neurogenic hypertensive dog: role of central beta-adrenoceptors (author's transl)].
    Montastruc P; Montastruc JL
    J Physiol (Paris); 1978; 74(7):651-8. PubMed ID: 218002
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of the central sympathoinhibitory action of ketanserin.
    McCall RB; Harris LT
    J Pharmacol Exp Ther; 1987 May; 241(2):736-40. PubMed ID: 3572820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension.
    Carey RM; Stote RM; Dubb JW; Townsend LH; Rose CE; Kaiser DL
    J Clin Invest; 1984 Dec; 74(6):2198-207. PubMed ID: 6150942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of sympathetic beta-adrenergic receptor on renin secretion in essential hypertension].
    Shigetomi S; Hashimoto S; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1982 Aug; 24(8):929-36. PubMed ID: 6294385
    [No Abstract]   [Full Text] [Related]  

  • 20. Suspected postprandial hypoglycemia is associated with beta-adrenergic hypersensitivity and emotional distress.
    Berlin I; Grimaldi A; Landault C; Cesselin F; Puech AJ
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1428-33. PubMed ID: 7962339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.